Neogen Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on March 29, 2026
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Neogen Chemicals has issued a corrigendum to its EGM notice scheduled for March 29, 2026, after NSE and BSE sought clarifications on the proposed preferential issue. The preferential issue involves 10 lakh equity shares allotted to Cadamba Solutions Private Limited (a promoter group entity owned by Dr. Harin Kanani) at Rs. 1,610 per share — a premium over the floor price of Rs. 1,375.82. The estimated total issue size is about Rs. 161 crore, with Rs. 100 crore earmarked for investment in wholly-owned subsidiary Neogen Ionics Limited (battery materials business), Rs. 21 crore for working capital, and Rs. 40 crore for general corporate purposes. The subsidiary funds will support a Rs. 1,500 crore capex project in Gujarat for Lithium-Ion battery electrolytes and specialty salts. The corrigendum also clarifies recent inter-se share transfers among promoter family members to family trusts under a SEBI exemption order, with no change in control of the company.
Shareholders are being asked to note updated disclosures ahead of the March 29 EGM vote on the preferential allotment. The Rs. 161 crore raise will dilute existing shareholders modestly, but proceeds are aimed at funding the high-growth battery materials subsidiary, which targets peak revenue of Rs. 2,500–2,950 crore. Approval at the EGM is a key near-term catalyst for the stock.